Literature DB >> 2792122

Alterations of in vitro interleukin 1 and 2 in diabetic children.

R Lorini1, D Montagna, A Lanfranchi, L Cortona, C Livieri, D Larizza, G d'Annunzio, F Severi.   

Abstract

We studied interleukin 1 (IL-1) and interleukin 2 (IL-2) production in unstimulated and stimulated cultures from 27 young diabetic patients and 21 age-matched healthy subjects. In unstimulated cultures monocytes from newly diagnosed patients produced significantly higher levels of IL-1 than controls. In lipopolysaccharide (LPS)-stimulated cultures, IL-1 production in patients with fresh and long-standing diabetes was no different from that of controls. IL-2 production was low or absent in unstimulated cultures from insulin-dependent diabetes mellitus (IDDM) patients and controls. In phytohaemagglutinin (PHA)-stimulated cultures both patient groups produced significantly less IL-2 than controls. No correlation was observed between IL-1, IL-2 production and HbA1 levels or the presence of HLA-DR3 or DR4. Our data on "spontaneous" IL-1 production support the hypothesis that monocytes from some newly diagnosed IDDM patients may circulate in a "preactivated" state. The low levels of IL-2 might be explained by an abnormal consumption or by the presence of increased soluble IL-2 receptor levels or by a serum factor which interferes with IL-2 production. Alternatively, it may be a genetically determined trait.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2792122     DOI: 10.1007/bf00443096

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  14 in total

1.  Enhanced interleukin 1 and depressed interleukin 2 production in juvenile arthritis.

Authors:  A Martini; A Ravelli; L D Notarangelo; R Maccario; A Lanfranchi; D Rondena; A G Ugazio; R Burgio
Journal:  J Rheumatol       Date:  1986-06       Impact factor: 4.666

Review 2.  Lymphokines.

Authors:  C A Dinarello; J W Mier
Journal:  N Engl J Med       Date:  1987-10-08       Impact factor: 91.245

3.  Is autoimmunity a side-effect of interleukin 2 production?

Authors:  G Krämer; K Schauenstein; G Wick
Journal:  Immunol Today       Date:  1986 Jul-Aug

4.  Auto-immunity in children with diabetes mellitus and in their relatives.

Authors:  R Lorini; D Larizza; C Livieri; V Cammareri; A Martini; A Plebani; D Zanaboni; F Severi
Journal:  Eur J Pediatr       Date:  1986-08       Impact factor: 3.183

5.  Cytotoxic anti-T cell antibodies in children with juvenile rheumatoid arthritis.

Authors:  K S Barron; D E Lewis; E J Brewer; D M Marcus; W T Shearer
Journal:  Arthritis Rheum       Date:  1984-11

6.  Acquired defect in interleukin-2 production in patients with type I diabetes mellitus.

Authors:  W A Kaye; M N Adri; J S Soeldner; S L Rabinowe; A Kaldany; C R Kahn; B Bistrian; S Srikanta; O P Ganda; G S Eisenbarth
Journal:  N Engl J Med       Date:  1986-10-09       Impact factor: 91.245

7.  Decreased synthesis of interleukin-2 (IL-2) in insulin-dependent diabetes mellitus.

Authors:  K S Zier; M M Leo; R S Spielman; L Baker
Journal:  Diabetes       Date:  1984-06       Impact factor: 9.461

8.  Cytokines and the chronic inflammation of rheumatic disease. I. The presence of interleukin-1 in synovial fluids.

Authors:  A M Nouri; G S Panayi; S M Goodman
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

9.  Interleukin 2: the molecule and its function.

Authors:  R J Robb
Journal:  Immunol Today       Date:  1984-07

10.  Hypothesis: the role of interleukins in lymphopoiesis - important in autoimmune disease?

Authors:  H M Dosch; A Shore
Journal:  J Rheumatol       Date:  1982 May-Jun       Impact factor: 4.666

View more
  5 in total

1.  Hyporesponsiveness to intradermal administration of hepatitis B vaccine in insulin dependent diabetes mellitus.

Authors:  S Li Volti; M Caruso-Nicoletti; F Biazzo; A Sciacca; G Mandarà; M Mancuso; F Mollica
Journal:  Arch Dis Child       Date:  1998-01       Impact factor: 3.791

2.  Imbalance of the interleukin 2 system in children with IDDM.

Authors:  T Tomoda; T Kurashige; T Taniguchi
Journal:  Diabetologia       Date:  1994-05       Impact factor: 10.122

3.  CD8+ dendritic cell-mediated tolerance of autoreactive CD4+ T cells is deficient in NOD mice and can be corrected by blocking CD40L.

Authors:  Jeffrey D Price; Nicole M Beauchamp; Gwendoline Rahir; Yongge Zhao; Cosima C Rieger; Annie W Lau-Kilby; Kristin V Tarbell
Journal:  J Leukoc Biol       Date:  2013-09-30       Impact factor: 4.962

4.  Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children.

Authors:  Yasar Dogan; Saadet Akarsu; Bilal Ustundag; Erdal Yilmaz; Metin Kaya Gurgoze
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

5.  Polymorphic variant at the IL2 region is associated with type 1 diabetes and may affect serum levels of interleukin-2.

Authors:  Marta Fichna; Magdalena Zurawek; Piotr Fichna; Iwona Ziółkowska-Suchanek; Danuta Januszkiewicz; Jerzy Nowak
Journal:  Mol Biol Rep       Date:  2013-10-24       Impact factor: 2.316

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.